How to maintain the maximal level of blinding in randomisation for a placebo-controlled drug trial. (2019)

First Author: Clifton L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.conctc.2019.100356

PubMed Identifier: 31011659

Publication URI: http://europepmc.org/abstract/MED/31011659

Type: Journal Article/Review

Volume: 14

Parent Publication: Contemporary clinical trials communications

ISSN: 2451-8654